US2003017130A1PendingUtilityA1

Additives enhancing topical applications of therapeutic agents

Assignee: TRISTRATA INCPriority: Dec 23, 1986Filed: Feb 8, 2002Published: Jan 23, 2003
Est. expiryDec 23, 2006(expired)· nominal 20-yr term from priority
A61K 8/42A61K 31/715A61Q 19/02A61K 8/60A61K 31/70A61K 8/494A61Q 19/10A61K 31/40A61K 45/06A61K 8/676A61K 8/671A61Q 19/08A61Q 17/00A61K 8/43A61K 8/375A61K 31/445A61Q 19/007A61K 8/675A61Q 19/008A61K 47/183A61K 31/195A61K 31/66A61K 31/20A61Q 5/006A61K 8/37A61K 31/7048A61K 8/365A61K 8/4953A61K 31/202A61K 31/365A61K 31/191A61K 9/0014A61Q 17/04A61K 31/19A61K 8/362A61K 8/63A61K 47/24A61K 47/26A61K 31/405A61Q 17/005A61Q 7/00A61K 31/366A61K 31/415A61K 8/4973A61Q 5/02A61K 8/347A61K 31/194A61K 8/38A61Q 19/00A61K 47/12
52
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Preventive as well as therapeutic treatment to alleviate cosmetic conditions and symptoms of dermatologic disorders with amphoteric compositions containing alpha hydroxyacids, alpha ketoacids, related compounds or polymeric forms of hydroxyacids is disclosed. The cosmetic conditions and the dermatologic disorders in which the amphoteric compositions and the polymeric compounds may be useful include dry skin, dandruff, acne, keratoses, psoriasis, eczema, pruritus, age spots, lentigines, melasinas, wrinkles, warts, blemished skin, hyperpigmented skin, kyperkeratotic skin, inflammatory dermatoses, skin changes associated with aging, and skin requiring cleansers.

Claims

exact text as granted — not AI-modified
We claim:  
     
         1 . A topical skin treating composition comprising: 
 a) an effective amount of at least one hydroxycarboxylic acid, wherein the at least one hydroxycarboxylic acid is present in the form of a free acid, lactone, or salt,    b) at least one agent selected from the group consisting of retinoids, wherein the agent is present in stereoisomeric or non-isomeric form, and    c) a cosmetically-acceptable vehicle.    
     
     
         2 . The composition of  claim 1 , wherein the composition is present in a formulation selected from the group consisting of a solution, a cream, an ointment, and a lotion composition for topical treatment or management of aging-related skin changes.  
     
     
         3 . The composition of  claim 2 , wherein the at least one hydroxycarboxylic acid is selected from the group consisting of glycolic acid, lactic acid, citric acid, tartaric acid, malic acid, methyllactic acid, mandelic acid, 4-hydroxymandelic acid, benzilic acid, ribonic acid, ribonolactone, gluconic acid, gluconolactone, galactonic acid, galactonolactone, glucoheptonic acid, glucoheptonolactone, glucuronic acid, glucuronolactone, galacuronic acid, galaturonolactone, glucaric acid, glucarolactone, galactaric acid, and galactarolactone.  
     
     
         4 . The composition of  claim 2 , wherein the composition is present in a formulation selected from the group consisting of a solution, a cream, an ointment, and a lotion composition for topical treatment or management of aging-related skin changes.  
     
     
         5 . The composition of  claim 1 , wherein the at least one agent is selected from the group consisting of retinol, retinal, retinoic acid, retinyl acetate, retinyl palmitate, methyl retinoate, ethyl retinoate, propyl retinoate and isopropyl retinoate.  
     
     
         6 . The composition of  claim 1 , wherein the at least one hydroxycarboxylic acid is selected from the group consisting of gluconolactone and glucarolactone, and the at least one agent is selected from the group consisting of retinol, retinyl acetate, retinyl pahnitate, retinal acid and retinoic acid.

Join the waitlist — get patent alerts

Track US2003017130A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.